Evaluating New Opportunities
When evaluating in-licensing opportunities, it is critical to include the payer perspective to ensure a realistic estimate of pricing and potential market size.
Likewise, gathering payers’ input on potential out-licensing opportunities can accelerate and enhance discussions with prospective partners. We provide expert support in both areas.
Navigating complex issues
Companies often have a very limited time to assess a new in-licensing opportunity.
Identifying and thinking through the relevant issues quickly, yet thoroughly, is essential.
It is important to think about opportunity costs, too. Avoiding expensive mistakes is important, yet no one wants to miss a valuable opportunity that might otherwise be snapped up by a competitor.
How we stand out
We can quickly get “inside the payer’s head”. Our team includes experienced former payers, and we have experience across virtually every therapy area. This gives us an unrivalled understanding of the payer’s perspective on almost any product.
We can assess how price-sensitive decision-makers would consider a new opportunity – including informed views on a likely reimbursed price level. And we’ll identify any significant access hurdles.
